Le Lézard
Classified in: Health
Subject: CCA

Mentice's CEO Göran Malmberg to present the company's Year-end Report Q4 2021 at a webcast conference call on February 3rd at 9:30 CET


STOCKHOLM, Jan. 27, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its year-end report via a webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.

To register for the presentation of the Year-end Report Q4 for the period October ? December 2021, which will be held on February 3rd at 09.30 CET, visit www.mentice.com/financial-reports-presentations.

The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

For further information, please contact:
Göran Malmberg, CEO, Mentice
Email: [email protected]
Tel US: +1 (312) 860 5610
Tel Sweden: +46 (0) 703 09 22 22

Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mentice-ab/r/mentice-s-ceo-goran-malmberg-to-present-the-company-s-year-end-report-q4-2021-at-a-webcast-conferenc,c3490191

SOURCE Mentice AB


These press releases may also interest you

at 22:20
The Sasakawa Peace Foundation (SPF), Citizen's Network for Global Activities (CINGA), and Forum for Refugees Japan (FRJ), are pleased to announce the opening of the Support Center for Refugees Japan (Support-R) in Tokyo on May 19, 2022. Russia's...

at 22:10
Global superstar and immersive entrepreneur, J Balvin, has announced the creation of OYE, the new bilingual, interactive wellness app. Balvin, the company's co-founder and Chief Dream Officer, co-founded OYE with happiness activist and ed-tech...

at 22:05
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its...

at 20:25
Cari M. Schwartz has been and is, currently, involved with many non-profit organizations that focus on healthcare needs of people across the country. As a Partner Attorney at Kantor & Kantor, LLP, it is her passion to bring education about patient's...

at 19:05
Imugene Limited , a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating...

at 19:00
Carebook Technologies Inc. ("Carebook" or the "Company") (XFRA: PMM1), a leading Canadian provider of innovative digital health solutions, is pleased to announce the completion of its rights offering (the "Rights Offering"), which expired at 5:00...



News published on 27 january 2022 at 03:46 and distributed by: